226 related articles for article (PubMed ID: 35932094)
1. Characterizing the epithelial-mesenchymal transition status of circulating tumor cells in head and neck squamous cell carcinoma.
Payne K; Brooks J; Batis N; Taylor G; Nankivell P; Mehanna H
Head Neck; 2022 Nov; 44(11):2545-2554. PubMed ID: 35932094
[TBL] [Abstract][Full Text] [Related]
2. Feasibility of mass cytometry proteomic characterisation of circulating tumour cells in head and neck squamous cell carcinoma for deep phenotyping.
Payne K; Brooks J; Batis N; Khan N; El-Asrag M; Nankivell P; Mehanna H; Taylor G
Br J Cancer; 2023 Nov; 129(10):1590-1598. PubMed ID: 37735243
[TBL] [Abstract][Full Text] [Related]
3. Dynamic changes of the EMT spectrum between circulating tumor cells and the tumor microenvironment in human papillomavirus-positive head and neck squamous cell carcinoma.
Ida S; Takahashi H; Tada H; Mito I; Matsuyama T; Chikamatsu K
Oral Oncol; 2023 Feb; 137():106296. PubMed ID: 36571985
[TBL] [Abstract][Full Text] [Related]
4. Epithelial-Mesenchymal Transition Status of Circulating Tumor Cells Is Associated With Tumor Relapse in Head and Neck Squamous Cell Carcinoma.
Tada H; Takahashi H; Ida S; Nagata Y; Chikamatsu K
Anticancer Res; 2020 Jun; 40(6):3559-3564. PubMed ID: 32487658
[TBL] [Abstract][Full Text] [Related]
5. Multiparameter analysis, including EMT markers, on negatively enriched blood samples from patients with squamous cell carcinoma of the head and neck.
Balasubramanian P; Lang JC; Jatana KR; Miller B; Ozer E; Old M; Schuller DE; Agrawal A; Teknos TN; Summers TA; Lustberg MB; Zborowski M; Chalmers JJ
PLoS One; 2012; 7(7):e42048. PubMed ID: 22844540
[TBL] [Abstract][Full Text] [Related]
6. Immediate Sample Fixation Increases Circulating Tumour Cell (CTC) Capture and Preserves Phenotype in Head and Neck Squamous Cell Carcinoma: Towards a Standardised Approach to Microfluidic CTC Biomarker Discovery.
Payne K; Brooks JM; Taylor GS; Batis N; Noyvert B; Pan Y; Nankivell P; Mehanna H
Cancers (Basel); 2021 Nov; 13(21):. PubMed ID: 34771681
[TBL] [Abstract][Full Text] [Related]
7. Prognostic Significance of Excision Repair Cross-Complementation Group 1 on Circulating Tumor Cells for Nasopharyngeal Carcinoma.
Liu T; Li Y; Song J; Li B; Wang R; Huang T; Qin Y
Cancer Control; 2024; 31():10732748241251562. PubMed ID: 38716503
[TBL] [Abstract][Full Text] [Related]
8. Circulating tumour cells in metastatic head and neck cancers.
Kulasinghe A; Perry C; Jovanovic L; Nelson C; Punyadeera C
Int J Cancer; 2015 Jun; 136(11):2515-23. PubMed ID: 25111594
[TBL] [Abstract][Full Text] [Related]
9. Classification of circulating tumor cells by epithelial-mesenchymal transition markers.
Wu S; Liu S; Liu Z; Huang J; Pu X; Li J; Yang D; Deng H; Yang N; Xu J
PLoS One; 2015; 10(4):e0123976. PubMed ID: 25909322
[TBL] [Abstract][Full Text] [Related]
10. Single-Cell Molecular Profiling of Head and Neck Squamous Cell Carcinoma Reveals Five Dysregulated Signaling Pathways Associated With Circulating Tumor Cells.
Stucky A; Viet CT; Aouizerat BE; Ye Y; Doan C; Mundluru T; Sedhiazadeh P; Sinha UK; Chen X; Zhang X; Li SC; Cai J; Zhong JF
Cancer Control; 2024; 31():10732748241251571. PubMed ID: 38869038
[TBL] [Abstract][Full Text] [Related]
11. Molecular detection of epithelial-mesenchymal transition markers in circulating tumor cells from pancreatic cancer patients: Potential role in clinical practice.
Zhao XH; Wang ZR; Chen CL; Di L; Bi ZF; Li ZH; Liu YM
World J Gastroenterol; 2019 Jan; 25(1):138-150. PubMed ID: 30643364
[TBL] [Abstract][Full Text] [Related]
12. Circulating Tumor Cells and Implications of the Epithelial-to-Mesenchymal Transition.
Lowes LE; Allan AL
Adv Clin Chem; 2018; 83():121-181. PubMed ID: 29304900
[TBL] [Abstract][Full Text] [Related]
13. Analysis of the hormone receptor status of circulating tumor cell subpopulations based on epithelial-mesenchymal transition: a proof-of-principle study on the heterogeneity of circulating tumor cells.
Guan X; Ma F; Liu S; Wu S; Xiao R; Yuan L; Sun X; Yi Z; Yang H; Xu B
Oncotarget; 2016 Oct; 7(40):65993-66002. PubMed ID: 27602758
[TBL] [Abstract][Full Text] [Related]
14. Mesenchymal marker and LGR5 expression levels in circulating tumor cells correlate with colorectal cancer prognosis.
Wang W; Wan L; Wu S; Yang J; Zhou Y; Liu F; Wu Z; Cheng Y
Cell Oncol (Dordr); 2018 Oct; 41(5):495-504. PubMed ID: 29949050
[TBL] [Abstract][Full Text] [Related]
15. Circulating Tumor Cells from Different Vascular Sites Exhibit Spatial Heterogeneity in Epithelial and Mesenchymal Composition and Distinct Clinical Significance in Hepatocellular Carcinoma.
Sun YF; Guo W; Xu Y; Shi YH; Gong ZJ; Ji Y; Du M; Zhang X; Hu B; Huang A; Chen GG; Lai PBS; Cao Y; Qiu SJ; Zhou J; Yang XR; Fan J
Clin Cancer Res; 2018 Feb; 24(3):547-559. PubMed ID: 29070526
[No Abstract] [Full Text] [Related]
16. Gene expression profiling of single circulating tumor cells in ovarian cancer - Establishment of a multi-marker gene panel.
Blassl C; Kuhlmann JD; Webers A; Wimberger P; Fehm T; Neubauer H
Mol Oncol; 2016 Aug; 10(7):1030-42. PubMed ID: 27157930
[TBL] [Abstract][Full Text] [Related]
17. The prognostic and therapeutic implications of circulating tumor cell phenotype detection based on epithelial-mesenchymal transition markers in the first-line chemotherapy of HER2-negative metastatic breast cancer.
Guan X; Ma F; Li C; Wu S; Hu S; Huang J; Sun X; Wang J; Luo Y; Cai R; Fan Y; Li Q; Chen S; Zhang P; Li Q; Xu B
Cancer Commun (Lond); 2019 Jan; 39(1):1. PubMed ID: 30606259
[TBL] [Abstract][Full Text] [Related]
18. EpCAM-independent isolation of circulating tumor cells with epithelial-to-mesenchymal transition and cancer stem cell phenotypes using ApoStream® in patients with breast cancer treated with primary systemic therapy.
Le Du F; Fujii T; Kida K; Davis DW; Park M; Liu DD; Wu W; Chavez-MacGregor M; Barcenas CH; Valero V; Tripathy D; Reuben JM; Ueno NT
PLoS One; 2020; 15(3):e0229903. PubMed ID: 32214335
[TBL] [Abstract][Full Text] [Related]
19. Current Status of Circulating Tumor Cells in Head and Neck Squamous Cell Carcinoma: A Review.
Aktar S; Baghaie H; Islam F; Gopalan V; Lam AK
Otolaryngol Head Neck Surg; 2023 May; 168(5):988-1005. PubMed ID: 36939466
[TBL] [Abstract][Full Text] [Related]
20. Mesenchymal circulating tumor cells (CTCs) and OCT4 mRNA expression in CTCs for prognosis prediction in patients with non-small-cell lung cancer.
Li S; Chen Q; Li H; Wu Y; Feng J; Yan Y
Clin Transl Oncol; 2017 Sep; 19(9):1147-1153. PubMed ID: 28374320
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
